These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 21087567)

  • 21. The use of octreotide to successfully treat protein-losing enteropathy following the Fontan operation.
    John AS; Phillips SD; Driscoll DJ; Warnes CA; Cetta F
    Congenit Heart Dis; 2011; 6(6):653-6. PubMed ID: 21545466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathophysiology and complications of Fontan circulation.
    Mazza GA; Gribaudo E; Agnoletti G
    Acta Biomed; 2021 Nov; 92(5):e2021260. PubMed ID: 34738582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment.
    Meadows J; Jenkins K
    Cardiol Young; 2011 Aug; 21(4):363-77. PubMed ID: 21349233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Early Glenn Operation May be Associated with the Later Occurrence of Protein-Losing Enteropathy in Fontan Patients : Association of Early Glenn and Failing Fontan.
    Unseld B; Stiller B; Borth-Bruhns T; du Bois F; Kroll J; Grohmann J; Fleck T
    Pediatr Cardiol; 2017 Aug; 38(6):1155-1161. PubMed ID: 28534240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Palliation for univentricular hearts].
    Shimazaki Y
    Rinsho Kyobu Geka; 1994 Jun; 14(3):198-201. PubMed ID: 9423091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein-losing enteropathy after Fontan operation.
    Rychik J
    Congenit Heart Dis; 2007; 2(5):288-300. PubMed ID: 18377444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical management of the failing Fontan.
    Ghanayem NS; Berger S; Tweddell JS
    Pediatr Cardiol; 2007; 28(6):465-71. PubMed ID: 17763892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early and late results of the modified fontan operation for heterotaxy syndrome 30 years of experience in 142 patients.
    Bartz PJ; Driscoll DJ; Dearani JA; Puga FJ; Danielson GK; O'Leary PW; Earing MG; Warnes CA; Hodge DO; Cetta F
    J Am Coll Cardiol; 2006 Dec; 48(11):2301-5. PubMed ID: 17161263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fontan and the pulmonary circulation: a potential role for new pulmonary hypertension therapies.
    Beghetti M
    Heart; 2010 Jun; 96(12):911-6. PubMed ID: 20538665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion.
    Odegard KC; Zurakowski D; DiNardo JA; Castro RA; McGowan FX; Neufeld EJ; Laussen PC
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):934-41. PubMed ID: 19327521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term clinical outcome of atrial isomerism after univentricular repair.
    Hoashi T; Ichikawa H; Fukushima N; Ueno T; Kogaki S; Sawa Y
    J Card Surg; 2009; 24(1):19-23. PubMed ID: 18778300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures - the importance of hemodynamics in the early postoperative period.
    Procelewska M; Kolcz J; Januszewska K; Mroczek T; Malec E
    Eur J Cardiothorac Surg; 2007 May; 31(5):866-72. PubMed ID: 17329113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous embolization of lymphatic fistulae as treatment for protein-losing enteropathy and plastic bronchitis in patients with failing Fontan circulation.
    Maleux G; Storme E; Cools B; Heying R; Boshoff D; Louw JJ; Frerich S; Malekzadeh-Milanii S; Hubrechts J; Brown SC; Gewillig M
    Catheter Cardiovasc Interv; 2019 Dec; 94(7):996-1002. PubMed ID: 31596530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fontan circulation: success or failure?
    Mondésert B; Marcotte F; Mongeon FP; Dore A; Mercier LA; Ibrahim R; Asgar A; Miro J; Poirier N; Khairy P
    Can J Cardiol; 2013 Jul; 29(7):811-20. PubMed ID: 23474138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein-losing enteropathy after Fontan operation.
    Hess J; Kruizinga K; Bijleveld CM; Hardjowijono R; Eygelaar A
    J Thorac Cardiovasc Surg; 1984 Oct; 88(4):606-9. PubMed ID: 6482492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcome of patients 20 years after Fontan operation--effect of fenestration on late morbidity.
    Ono M; Boethig D; Goerler H; Lange M; Westhoff-Bleck M; Breymann T
    Eur J Cardiothorac Surg; 2006 Dec; 30(6):923-9. PubMed ID: 17074498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation.
    John AS; Driscoll DJ; Warnes CA; Phillips SD; Cetta F
    Ann Thorac Surg; 2011 Oct; 92(4):1451-6. PubMed ID: 21784410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastro-intestinal protein loss in late survivors of Fontan surgery and other congenital heart disease.
    Thorne SA; Hooper J; Kemp M; Somerville J
    Eur Heart J; 1998 Mar; 19(3):514-20. PubMed ID: 9568457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies to treat protein-losing enteropathy.
    Rychik J; Spray TL
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2002; 5():3-11. PubMed ID: 11994860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Clinical Profiles in Patients with Protein-Losing Enteropathy With and Without Fontan Circulation.
    Ono S; Ohuchi H; Miyazaki A; Yamada O
    Pediatr Cardiol; 2018 Oct; 39(7):1290-1298. PubMed ID: 29789917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.